Other GLP-1 medications contain different active ingredients, and some have an added component by mimicking another hormone called glucose-dependent insulinotropic polypeptide (GIP)
While the FDA-approved medications are administered via either an oral tablet or pre-filled pens, compounded versions of semaglutide have patients draw the dose themselves from vials, which can lead to dosing errors
Baig K, Dusetzina SB, Kim DD, Leech AA
Wegovy is also FDA-approved to reduce the risk of experiencing a major cardiovascular event (e.g
Short-term consequences include symptoms such as excessive thirst, frequent urination, fatigue, and blurred vision
Research has shown that semaglutide can reduce the risk of death from non-fatal heart attack or stroke by about 20%